Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.
Blood|November 23, 2020
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALLPraveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Pediatric Blood & Cancer|October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
Blood Advances|December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Blood|October 26, 2019
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALLKevin J Curran, Steven P Margossian, Nancy A Kernan, et al.
Blood|November 23, 2020
Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALLPraveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Pediatric Blood & Cancer|October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Pageof 19